Atkinson Edward Morrow III sold VRTX
February 11, 2025 · Form 4 insider transaction
Atkinson Edward Morrow III sold 1,747 shares of Vertex Pharmaceuticals Incorporated at $459.83 per share, a transaction worth $803.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,747
Price
$459.83
Total value
$803.3K
InsiderAtkinson Edward Morrow III
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 11, 2025
Filing dateFebruary 12, 2025
Shares owned after23,225
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024.